Insmed
INSM
#961
Rank
$25.09 B
Marketcap
$114.40
Share price
5.19%
Change (1 day)
-40.39%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2023 (TTM): -$5.27

According to Insmed's latest financial reports the company's current EPS (TTM) is -$2.82. In 2022 the company made an earnings per share (EPS) of -$3.90 a decrease over its 2021 EPS that were of -$3.87.

EPS history for Insmed from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.2735.13%
2022-$3.900.78%
2021-$3.8728.57%
2020-$3.01-0.99%
2019-$3.04-27.96%
2018-$4.2247.55%
2017-$2.860.7%
2016-$2.8439.9%
2015-$2.039.73%
2014-$1.8517.09%
2013-$1.580.64%
2012-$1.57-46.42%
2011-$2.93497.96%
2010-$0.49-105.1%
2009$9.61-850.78%
2008-$1.28-24.71%
2007-$1.70-71.67%
2006-$6.00-28.57%
2005-$8.4023.53%
2004-$6.80134.48%
2003-$2.90-73.64%
2002-$11.00-2.65%
2001-$11.30-86.64%
2000-$84.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
$5.25-286.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-$3.10 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$17.33-714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-$2.63-6.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$0.75-73.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-$0.98-65.25%๐Ÿ‡บ๐Ÿ‡ธ USA